Clinical Trial Update: Phase 3 Study to Treat Patients With Soft Tissue Sarcomas [Phase 3]

View source ↗

Summary

Phase 3 study in metastatic, locally advanced or unresectable soft tissue sarcoma completed; results were posted in June 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• ImmunityBio investigational therapy

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma | Phase 3 | Status: COMPLETED | Results posted: 2024-06-13